Buprenorphine
Trade Names: BuTrans, Sublocade, Subutex
Uses
- Management of severe and persistent pain
- Management treatment of moderate to severe opioid use disorder
- Opioid withdrawal in heroin-dependent hospitalized patients
- Perineural anesthesia
Adverse Effects
Considerations for PT
Consider timing for pain relief prior to Physiotherapy intervention
Route of Administration
Buccal film
Intramuscular (IM)
Intravenous (IV)
Subcutaneous
Sublingual
Transdermal
Mechanism of Action
Binds to specific opioid receptors in the central nervous system (partial agonist at mu-opioid receptors and antagonist at kappa-opioid receptors), causing:
- Relief of withdrawal and cravings in individuals with opioid dependence
- Inhibition of ascending pain pathways
- Alteration of pain perception and response to pain
Drug Dynamics
Time to Peak Effect
1 hour to 4 hours
Duration of Action
12 hours
Time to Onset
30 minutes to 60 minutes
Resources
*Some links accessed via VCH Intranet
Last updated: April 30, 2026